{"database": "lobbying", "table": "lobbying_activities", "rows": [[3005841, "b3860da1-d311-4999-a41f-76a8976b954a", "Q2", "PORT SIDE STRATEGIES, LLC", 401105394, "NEW VENTURE FUND", 2023, "second_quarter", "PHA", "Issues related to implementation of the drug pricing provisions of the Inflation Reduction Act of 2022. H.R.485 - Protecting Health Care for All Patients Act of 2023 - opposed. S. 1264 - SMART Prices Act - in support. S. 1323 - End Price Gouging for Medications Act - in support. S. 2157 - A bill to repeal prescription drug price control provisions of the Inflation Reduction Act - opposed. S. 1339 - Pharmacy Benefit Manager Reform Act - in support. S. 1214 - RARE Act - in support. S. 1114 - Expanding Access to Low-Cost Generics Act of 2023 - in support. S.1067 - Ensuring Timely Access to Generics Act of 2023 - in support.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2023-07-16T15:00:08-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3005841"], "units": {}, "query_ms": 0.32023200765252113, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}